enVVeno Medical Corp
envveno.comWhat Do They Do?
Develops a minimally invasive replacement venous valve for severe chronic venous insufficiency, intended for use by vascular surgeons, interventional radiologists and interventional cardiologists treating patients.
10-K for FY2025, filed Mar 26, 2026enVVeno Medical Corporation is a medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to…View ↗
The Company first developed the VenoValve®, which was a first-in-class surgical replacement venous valve (the Company received a…View ↗
The enVVe System is designed to treat severe deep chronic venous insufficiency (“CVI”) through a minimally invasive, catheter-based…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Jul 30, 2026
−$3.6MView ↗
- ▼ −46% (Loss)
- vs −$6.7M in Q2 FY2025
Focus shifts to enVVe
The older report described both VenoValve, a surgical valve, and enVVe, a non-surgical valve, in development. The latest report focuses on enVVe after the FDA sent a non-approvable letter for VenoValve.
10-K for FY2022, filed Mar 2, 2023 10-K for FY2025, filed Mar 26, 2026The Company’s lead product is the VenoValve®, which is a first-in-class surgical replacement venous valve that is currently being evaluated…View ↗
Loading...
